Evidence map›Paper›PMID 39560710›Full record

ArticleCEN case reports2025

Subclinical acute tubular necrosis potentially associated with red yeast rice consumption unexpectedly detected in a patient with membranous nephropathy.

Narumichi Iwamura, Kanako Tsutsumi, Shunsuke Yamada, Noriko Uesugi, Takafumi Hamashoji, Yui Arita, Takashi Deguchi, Toshiaki Nakano

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Narumichi IwamuraDepartment of Nephrology, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan.
Kanako TsutsumiDepartment of Nephrology, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan.
Shunsuke YamadaDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Noriko UesugiDepartment of Pathology, Fukuoka University, Fukuoka, Japan.
Takafumi HamashojiDepartment of Nephrology, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan.
Yui AritaDepartment of Nephrology, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan.
Takashi DeguchiDepartment of Nephrology, Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Japan.
Toshiaki NakanoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. nakano.toshiaki.455@m.kyushu-u.ac.jp.ORCID 0000-0001-9235-5615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In March 2024, a significant public health issue involving red yeast rice supplements emerged in Japan, which may have been associated with several health problems, including kidney dysfunction. A 74-year-old man without a history of urinary abnormalities developed nephrotic syndrome 10 weeks after starting "Beni-Koji Choleste Help

Indexed as

Biological ProductsDietary SupplementsGlomerulonephritis, MembranousKidney Tubular Necrosis, AcuteAgedHumansJapanMaleNephrotic SyndromePrednisoloneReceptors, Phospholipase A2Biological ProductsPrednisoloneReceptors, Phospholipase A2red yeast riceAcute tubular necrosisBeni-Koji Choleste Help®Membranous nephropathyNephrotic syndromeRed yeast rice

Identifiers

PMID39560710
PMCPMC12307268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.